Med Worm: Keyword Buprenorphine

Subscribe to Med Worm: Keyword Buprenorphine feed
MedWorm.com provides a medical RSS filtering service. Thousands of medical RSS feeds are combined and output via different filters. This feed contains the latest news in Suboxone
Updated: 39 min 45 sec ago

Rapid Growth in Medicaid Spending on Medications to Treat Opioid Use Disorder and Overdose (June 2017)

July 11, 2017 - 4:46am
Report used state Medicaid drug utilization files from 2011 to 2016 to assess spending on buprenorphine, naltrexone, and naloxone prescriptions. (Source: HSR Information Central)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Heroin Addiction: How My Father Saved Me

June 16, 2017 - 10:25am
I was a breech birth ― feet first, my head got stuck in the birth canal. My father brought me to Children’s Hospital in Boston. The doctors diagnosed me with Cerebral Palsy. They told him that the loss of oxygen to my brain had destroyed a portion of the frontal lobe. But my father was a tough Irish Catholic, old-school warrior. He refused to listen to them. No son of his was going to be a cripple. He found a doctor that told him how he could take the place of my injured brain. Every day, he laid me on the floor and exercised my legs. The muscles in my right leg were all shrunken and twisted. His job was to straighten them. Back and forth, up and down, he stretched them until the heels of my feet evenly matched. My mother told me the sound of me screaming was so unbearable that the...

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

'All Scientific Hands On Deck' To End The Opioid Crisis

June 1, 2017 - 11:46am
By Nora Volkow (Director, NIDA) and Francis Collins (Director, NIH) In 2015, 2 million people had a prescription opioid use disorder and 591,000 suffered from a heroin use disorder; prescription drug misuse alone cost the nation $78.5 billion in health care, law enforcement, and lost productivity. But while the scope of the crisis is staggering, it is not hopeless. We understand opioid addiction better than many other drug use disorders; there are effective strategies that can be implemented right now to save lives and to prevent and treat opioid addiction. At the National Rx Drug Abuse and Heroin Summit in Atlanta, GA last month, lawmakers and representatives from healthcare, law enforcement, and many private stakeholders from across the nation affirmed a strong commitment to end the cris...

Trump's Approach To The Opioid Epidemic: Neglect Treatment, Ignore The Experts

May 24, 2017 - 4:34pm
WASHINGTON – Since taking office, President Donald Trump has systematically removed or limited the power of federal officials and government offices that have the expertise to confront the nation’s opioid epidemic. Trump asked Surgeon General Vivek Murthy to resign in late April. He still has an acting director running the Centers for Disease Control and Prevention. Although he backtracked on his reported plan to essentially gut his Office of National Drug Control Policy, staffers would be wise to polish their resumes.  Trump’s new budget proposal cuts all federal drug prevention programs by roughly 11 percent. The former director of the CDC, Dr. Tom Frieden, vented on Twitter that the 1.2 billion cut to his former agency would thwart efforts at preventing the ...

FDA OKs Bunavail for Induction of Opioid Addiction Treatment FDA OKs Bunavail for Induction of Opioid Addiction Treatment

May 2, 2017 - 12:24pm
The FDA has broadened the indication for Bunavail (buprenorphine and naloxone) buccal film to include induction of buprenorphine treatment for opioid dependence.FDA Approvals (Source: Medscape Psychiatry Headlines)

FDA OKs BioDelivery Sciences ’ Bunavail opioid dependence film

May 2, 2017 - 10:22am
BioDelivery Sciences International (NSDQ:BDSI) said today that the FDA approved a supplemental new drug application for its Bunavail buprenorphine and naloxone buccal film. The revised indication allows patients to use the product to initiate buprenorphine treatment for opioid dependence. Induction is the initial process by which a patient transitions from abusing an opioid to buprenorphine treatment which is designed to relieve cravings and withdrawal, according to BioDelivery Sciences. Get the full story at our sister site, Drug Delivery Business News. The post FDA OKs BioDelivery Sciences’ Bunavail opioid dependence film appeared first on MassDevice. (Source: Mass Device)